Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Manulife, Sun Life warn of more COVID-19 hurdles in Asia

Published 11/04/2021, 10:51 AM
Updated 11/04/2021, 10:57 AM
© Reuters.

By Nichola Saminather

TORONTO (Reuters) - Senior executives at Canada's two biggest life insurers said on Thursday they were bracing for more COVID-19 related uncertainties in their fastest-growing market of Asia after a resurgence of the virus and lockdowns in the region weighed on their quarterly earnings.

Manulife Financial (NYSE:MFC) Corp and Sun Life Financial (NYSE:SLF) Inc have been targeting expansion in the region, which has been their growth engine in many past quarters. But waves of COVID-19 that have hit different countries at different times and repeated lockdowns have increased claims and weighed on business growth.

"What we have experienced in Asia from time to time is that there is the resurgence of COVID and the containment measures do come back and have an impact on volumes," Anil Wadhwani, chief executive of Manulife's Asian business, said on an analyst call on Thursday. "We don't believe that the recovery is going to be immediate."

Manulife's core profit from Asia fell almost 5% due to pandemic-related challenges in Indonesia, the Philippines and Vietnam, but growth in asset management and Canada earnings helped drive a 4.5% increase in company-wide profit.

Smaller rival Sun Life paid out almost C$87 million ($70 million) in total claims related to COVID-19 this quarter, bringing payments since the pandemic began to about C$700 million, Sun Life's Chief Executive Kevin Strain told Reuters.

Death claims related to COVID-19 in Indonesia, the Philippines and India contributed to a 12% reduction in underlying earnings for Asia in the third quarter from a year earlier for Sun Life.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Its U.S. business also came under some pressure from the pandemic, with the three months through September the worst for death claims related to COVID-19 for working-age people, Strain said.

Underlying profit overall rose 7% thanks to strength in its asset management unit, and the company raised its medium-term return on equity target to over 16% from the current 12-14%.

"It's hard to tell whether there's going to be new variants," Strain said in an interview, referring to the virus. "What you are seeing in Asia is higher vaccination rates. That should help in terms of claims, but I don't think we're out of COVID yet."

Sun Life shares fell 0.8% to C$70.80 in morning trading in Toronto. Manulife shares dropped 2.6% to C$24.36. The Toronto stock benchmark added 0.5%.

($1 = 1.2431 Canadian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.